V
主页
京东 11.11 红包
Gut microbiota profile and selected plasma metabolites in type 1 diabetes withou
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
复杂膈疝修补术(3部分) 博士生导师手术展播
毕业大论文第一章绪论怎么写,视频简介有模板
Role of the gut microbiota in type 2 diabetes and related diseases
Gut microbiota and CKD
PSH regulates the gut microbiota and improves mucosal barrier injury in CKD rats
Role of gut microbiota & microbiota-related serum metabolites in DKD progression
Fungal gut microbiota dysbiosis in systemic lupus erythematosus
Gut microbiota contributes to the development of hypertension in a genetic mouse
Aberrant gut microbiota alters host metabolome and impacts renal failure
Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Dia
QingReXiaoZheng Formula Modulates Gut Microbiota and Inhibits Inflammation in DKD
The Host Shapes the Gut Microbiota via Fecal microRNA
LncRNAlncLy6C induced by microbiota metabolite
Gut microbiota dysbiosis-induced activation of the RAS
Metabolic Effects of Dapagliflozin with Type 1 Diabetes
Interaction between drugs and the gut microbiome
Compositional alterations of Gut microbiota between the patients with DKD and DM
Plasma TMAO in Predicting CVD and Renal Complicationgs in Individuals with T1DM
igD multiple myeloma diease profile therapeutic response and survival
gut microbial biotin metabolism and host biotin status
Gut microbiome dysbiosis contributes to the development of hypertension
Berberine ameliorates CKD through inhibiting gut-derived uremic toxin production
Moutan Cortex polysaccharide ameliorates diabetic kidney disease via Gut microbe
SYKFT alleviates DKD through attenuating inflammation and modulating gut microbes
Temporal variability in quantitative human gut microbiome profiles.
intestinal microbiota control acute kidney injury severity by immune modulation
诺欣妥和奥美沙坦对原发性高血压患者心血管重塑的影响
SGLT2抑制剂对于肾脏的影响
LncRNA SOX2OT通过Akt/mTOR介导的自噬减轻糖尿病肾病肾小球系膜细胞增殖和纤维化
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Rec
沙库巴曲缬沙坦降低射血分数保留型心衰患者收缩压
3-Hydroxybutyrate Ameliorates the Progression of Diabetic Nephropathy
Canagliflozin reduces inflammation and fibrosis biomarkers
Urinary metabolite profiling and risk of progression of DN
Polysaccharides from AT ameliorate renal damage in type 2 diabetic mice
NCAM1 is novel autoantigen in MLN
Endogenous adenine mediates kidney injury in diabetic models and predicts DKD in
Protocadherin 7-Associated Membranous Nephropathy
LN guideline
Concurrent IgA Nephropathy and Membranous Nephropathy